Dysentery is the name of the drug furazolidone, and b6 should refer to vitamin B6, both are not suitable for all patients with atrophic gastritis and the specific efficacy varies from person to person, only taking furazolidone and vitamin B6, may not be able to effectively treat atrophic gastritis. Furazolidone is a commonly used antibiotic against Helicobacter pylori infection, so it can be used for atrophic gastritis caused by Helicobacter pylori infection, but it needs to be combined with other antibiotics (e.g., amoxicillin), proton pump inhibitors (e.g., omeprazole), and bismuth (e.g., flucytosine). Patients with atrophic gastritis need to be supplemented with vitamin B12 because of anemia and vitamin B12 deficiency after progression to atrophy of the gastric body, while those with nausea and vomiting can be treated with vitamin B6. Vitamin B6 does not fundamentally reverse the lesions, but it can alleviate the patient’s discomfort. It should also be noted that furazolidone is not effective in treating atrophic gastritis caused by duodenal-gastric reflux, autoimmune diseases, etc., and the efficacy of these two drugs may vary depending on the individual’s physical condition and the severity of the disease. In conclusion, those who are diagnosed with atrophic gastritis must choose and adjust the medication and other treatment methods under the guidance of a doctor according to the cause of the disease and the actual situation, and must not dispose of the medication on their own and use it blindly, so as not to intervene inappropriately, resulting in undesirable consequences.